OA
IRWD icon

Oak Associates’s Ironwood Pharmaceuticals IRWD Stock Holding History

Oak Associates’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-61,384
Closed -$400K – 133
2024
Q2 		$400K Hold
61,384
– – 0.03% 127
2024
Q1 		$535K Hold
61,384
– – 0.04% 121
2023
Q4 		$702K Hold
61,384
– – 0.05% 111
2023
Q3 		$591K Buy
61,384
+9,517
+18% +$93.3K 0.05% 112
2023
Q2 		$552K Sell
51,867
-169,422
-77% -$1.82M 0.04% 116
2023
Q1 		$2.33M Buy
221,289
+11,340
+5% +$127K 0.19% 75
2022
Q4 		$2.6M Buy
209,949
+174,849
+498% +$1.98M 0.22% 74
2022
Q3 		$364K Buy
+35,100
New +$398K 0.03% 123

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Oak Associates's IRWD Position: Q3 2024 in Review

Oak Associates sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2024, closing a stake of 61,384 shares — an estimated $400K sold.

Oak Associates first reported a position in IRWD in Q3 2022 and held it in 8 quarters. The position peaked at $2.6M in Q4 2022. 221 funds tracked by Wall St. Rank hold IRWD as of Q3 2024.

  • Oak Associates reported no remaining Ironwood Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Oak Associates sold 61,384 Ironwood Pharmaceuticals shares in Q3 2024, an estimated $400K.
  • Oak Associates first reported a position in Ironwood Pharmaceuticals in Q3 2022 and held it in 8 quarters.
  • Oak Associates's Ironwood Pharmaceuticals position peaked at $2.6M in Q4 2022.
  • 221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2024.

Based on Oak Associates's 13F filing for Q3 2024, filed 12 Nov 2024.